Add to ORKGThe cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC) are responsible for tumor initiation. CSC from several human carcinomas are characterized by specific cell surface markers, such as CD133. The CD133 role in colon tumorigenesis remains controversial
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Stage I colorectal carcinomas display a highly variable behavior which is not accurately predicted b...
Emerging evidence suggests that tumors contain and are driven by a cellular component that displays ...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
INTRODUCTION: Recent evidence based on cancer stem cell (CSC) models, is boosting the progress of tr...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
According to the cancer stem cell (CSC) model, higher CD133 expression in tumor tissue is associated...
<div><p>According to the cancer stem cell (CSC) model, higher CD133 expression in tumor tissue is as...
Experimental data indicate that colorectal cancer cells with CD133 expression exhibit enhanced tumor...
CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal ...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
Although relatively good therapeutic results are achieved in non-advanced cancer, the prognosis of t...
SummaryA novel paradigm in tumor biology suggests that cancer growth is driven by stem-like cells wi...
Cancer stem cells are defined as cells able to both extensively selfrenew and differentiate into pro...
Background: Colorectal cancer (CRC) is one of the most common malignancies in the world. The cancer ...
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Stage I colorectal carcinomas display a highly variable behavior which is not accurately predicted b...
Emerging evidence suggests that tumors contain and are driven by a cellular component that displays ...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
INTRODUCTION: Recent evidence based on cancer stem cell (CSC) models, is boosting the progress of tr...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
According to the cancer stem cell (CSC) model, higher CD133 expression in tumor tissue is associated...
<div><p>According to the cancer stem cell (CSC) model, higher CD133 expression in tumor tissue is as...
Experimental data indicate that colorectal cancer cells with CD133 expression exhibit enhanced tumor...
CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal ...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
Although relatively good therapeutic results are achieved in non-advanced cancer, the prognosis of t...
SummaryA novel paradigm in tumor biology suggests that cancer growth is driven by stem-like cells wi...
Cancer stem cells are defined as cells able to both extensively selfrenew and differentiate into pro...
Background: Colorectal cancer (CRC) is one of the most common malignancies in the world. The cancer ...
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Stage I colorectal carcinomas display a highly variable behavior which is not accurately predicted b...
Emerging evidence suggests that tumors contain and are driven by a cellular component that displays ...